Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-23

Clinical Trial Update: Strategy to Improve Adherence of Roflumilast [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describes strategies to improve adherence to roflumilast in patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daliresp (roflumilast)

Snippet

Sponsor: Asan Medical Center | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: UNKNOWN